☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Fulcrum Therapeutics
Fulcrum Therapeutics Partners with Sanofi to Develop and Commercialize Losmapimod for Facioscapulohumeral Muscular Dystrophy
May 13, 2024
Fulcrum Therapeutics Signs an Exclusive License Agreement with CAMP4 Therapeutics to Advance Novel Therapies for Rare Hematologic...
July 11, 2023
PharmaShots' Key Highlights of Second Quarter 2021
July 7, 2021
PharmaShots Weekly Snapshots (May 10 - 14, 2021)
May 14, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.
